"Prokalcitonin v diagn\u00F3ze bakteri\u00E1ln\u00ED infekce u nemocn\u00FDch s autoimunitn\u00EDmi revmatick\u00FDmi chorobami" . "P(NR9291)" . . "Procalcitonin; diagnosis; bacterial; infection; patients; autoimmune; diseases"@en . "445298" . . "4"^^ . . "2"^^ . . . . "Prokalcitonin v diagn\u00F3ze bakteri\u00E1ln\u00ED infekce u nemocn\u00FDch s autoimunitn\u00EDmi revmatick\u00FDmi chorobami"@cs . . . "RIV/00023728:_____/07:00000306" . "Progn\u00F3za pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes je zlep\u0161ena d\u00EDky imunosupresivn\u00ED l\u00E9\u010Db\u011B. Tato l\u00E9\u010Dba spolu s imunologick\u00FDmi abnormalitami v r\u00E1mci z\u00E1kladn\u00EDho onemocn\u011Bn\u00ED v\u0161ak vede ke zv\u00FD\u0161en\u00E9mu riziku z\u00E1va\u017En\u00FDch infekc\u00ED. Odli\u0161en\u00ED vzplanut\u00ED choroby od infek\u010Dn\u00ED komplikace je obt\u00ED\u017En\u00E9. Prokalcitonin je biomarkerem, kter\u00FD je dosud vyu\u017E\u00EDv\u00E1n zejm\u00E9na u kriticky nemocn\u00FDch pacient\u016F v diferenci\u00E1ln\u00ED diagn\u00F3ze syst\u00E9mov\u00E9 z\u00E1n\u011Btliv\u00E9 odpov\u011Bdi bakteri\u00E1ln\u00ED a nebakteri\u00E1ln\u00ED etiologie"@cs . . "\u010Cesk\u00E1 revmatologie" . "Procalcitonin in the diagnosis of bacterial infection in patients with autoimmune diseases"@en . . "CZ - \u010Cesk\u00E1 republika" . . . "Progn\u00F3za pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes je zlep\u0161ena d\u00EDky imunosupresivn\u00ED l\u00E9\u010Db\u011B. Tato l\u00E9\u010Dba spolu s imunologick\u00FDmi abnormalitami v r\u00E1mci z\u00E1kladn\u00EDho onemocn\u011Bn\u00ED v\u0161ak vede ke zv\u00FD\u0161en\u00E9mu riziku z\u00E1va\u017En\u00FDch infekc\u00ED. Odli\u0161en\u00ED vzplanut\u00ED choroby od infek\u010Dn\u00ED komplikace je obt\u00ED\u017En\u00E9. Prokalcitonin je biomarkerem, kter\u00FD je dosud vyu\u017E\u00EDv\u00E1n zejm\u00E9na u kriticky nemocn\u00FDch pacient\u016F v diferenci\u00E1ln\u00ED diagn\u00F3ze syst\u00E9mov\u00E9 z\u00E1n\u011Btliv\u00E9 odpov\u011Bdi bakteri\u00E1ln\u00ED a nebakteri\u00E1ln\u00ED etiologie" . "Prognosis of patients with systemic lupus erythematosus is improved due to immunosuppressive treatment. However, the treatment and immunological abnormalities as a consequence of the disease, can contribute to increased risk for serious infections. Discrimination between flare of the disease and infectious complication is difficult. Procalcitonin is a biomarker that is currently used to differentiate systemic inflammatory response of bacterial and non-bacterial etiology in critically ill patients"@en . . . . "Procalcitonin in the diagnosis of bacterial infection in patients with autoimmune diseases"@en . "1210-7905" . "Prokalcitonin v diagn\u00F3ze bakteri\u00E1ln\u00ED infekce u nemocn\u00FDch s autoimunitn\u00EDmi revmatick\u00FDmi chorobami"@cs . . "Dejmkov\u00E1, Helena" . "Prokalcitonin v diagn\u00F3ze bakteri\u00E1ln\u00ED infekce u nemocn\u00FDch s autoimunitn\u00EDmi revmatick\u00FDmi chorobami" . . "RIV/00023728:_____/07:00000306!RIV10-MZ0-00023728" . . "Pavelka, Karel" . . "4" . . "15" . "[16747BACE432]" . "Uhrov\u00E1, J." . "3"^^ .